SARS-CoV-2 triggering autoimmune diseases

被引:68
|
作者
Mobasheri, Leila [1 ]
Nasirpour, Mohammad Hossein [2 ]
Masoumi, Elham [3 ,4 ]
Azarnaminy, Afsaneh Foolady [5 ]
Jafari, Mozhdeh [6 ,7 ]
Esmaeili, Seyed-Alireza [6 ,7 ]
机构
[1] Mashhad Univ Med Sci, Fac Med, Dept Pharmacol, Mashhad, Razavi Khorasan, Iran
[2] Natl Inst Genet Engn & Biotechnol NIGEB, Inst Med Biotechnol, Dept Med Genet, Tehran, Iran
[3] Ilam Univ Med Sci, Sch Med, Dept Immunol, Ilam, Iran
[4] Ilam Univ Med Sci, Sch Med, Student Res Comm, Ilam, Iran
[5] Social Secur Org Hosp, Dept Anesthesiol, Ardebil, Iran
[6] Mashhad Univ Med Sci, Immunol Res Ctr, Mashhad, Razavi Khorasan, Iran
[7] Mashhad Univ Med Sci, Fac Med, Immunol Dept, Mashhad, Razavi Khorasan, Iran
关键词
SARS-CoV-2; Covid-19; Autoimmune disease; Autoimmunity; Cytokine; MOLECULAR MIMICRY; TOLEROGENIC PROBIOTICS; CLINICAL-FEATURES; MYASTHENIA-GRAVIS; T-CELLS; COVID-19; IMMUNOPATHOGENESIS; PATHOGENESIS; VACCINATION; EXPRESSION;
D O I
10.1016/j.cyto.2022.155873
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autoimmunity, hyperstimulation of the immune system, can be caused by a variety of reasons. Viruses are thought to be important environmental elements that contribute to the development of autoimmune antibodies. It seems that viruses cause autoimmunity with mechanisms such as molecular mimicry, bystander activation of T cells, transient immunosuppression, and inflammation, which has also been seen in post-Covid-19 autoimmunity. Infection of respiratory epithelium by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) dysregulates the immune response, triggers both innate and acquired immunity that led to the immune system's hyperactivation, excessive cytokine secretion known as "cytokine storm, " and finally acute respiratory distress syndrome (ARDS) associated with high mortality. Any factor in the body that triggers chronic inflammation can contribute to autoimmune disease, which has been documented during the Covid-19 pandemic. It has been observed that some patients produce autoantibody and autoreactive CD4(+) and CD8(+) T cells, leading to the loss of self-tolerance. However, there is a scarcity of evidence defining the precise molecular interaction between the virus and the immune system to elicit autoreactivity. Here, we present a review of the relevant immunological findings in Covid-19 and the current reports of autoimmune disease associated with the disease.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Autoimmune phenomena following SARS-CoV-2 vaccination
    Ishay, Yuval
    Kenig, Ariel
    Tsemach-Toren, Tehila
    Amer, Radgonde
    Rubin, Limor
    Hershkovitz, Yoav
    Kharouf, Fadi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99
  • [42] Autoimmune hepatitis triggered by SARS-CoV-2 vaccination
    Vuille-Lessard, Elise
    Montani, Matteo
    Bosch, Jaume
    Semmo, Nasser
    JOURNAL OF AUTOIMMUNITY, 2021, 123
  • [43] SARS-CoV-2 mRNA vaccines do not worsen autoimmunity in patients with autoimmune liver diseases
    Kalin, Tobias
    Passarin, Katia
    Filipowic-Sinnreich, Magdalena
    Semela, David
    Seifert, Tanja
    Sallusto, Federica
    Vergani, Diego
    Cerny, Andreas
    Mieli-Vergani, Giorgina
    Beretta-Piccoli, Benedetta Terziroli
    JOURNAL OF AUTOIMMUNITY, 2024, 149
  • [44] Correction to: Incident autoimmune diseases in association with SARS-CoV-2 infection: A matched cohort study
    Falko Tesch
    Franz Ehm
    Annika Vivirito
    Danny Wende
    Manuel Batram
    Friedrich Loser
    Simone Menzer
    Josephine Jacob
    Martin Roessler
    Martin Seifert
    Barbara Kind
    Christina König
    Claudia Schulte
    Tilo Buschmann
    Dagmar Hertle
    Pedro Ballesteros
    Stefan Baßler
    Barbara Bertele
    Thomas Bitterer
    Cordula Riederer
    Franziska Sobik
    Lukas Reitzle
    Christa Scheidt-Nave
    Jochen Schmitt
    Clinical Rheumatology, 2023, 42 : 2919 - 2920
  • [45] SARS-CoV-2 as a Potential Trigger of Neurodegenerative Diseases
    Gomez-Pinedo, Ulises
    Matias-Guiu, Jorge
    Sanclemente-Alaman, Inmaculada
    Moreno-Jimenez, Lidia
    Montero-Escribano, Paloma
    Matias-Guiu, Jordi A.
    MOVEMENT DISORDERS, 2020, 35 (07) : 1104 - 1105
  • [46] SARS-CoV-2 Vaccination and Autoimmune Neuropathies: Rebalancing the Risk
    Allen, Jeffrey A.
    NEUROLOGY, 2023, 100 (02) : 55 - 56
  • [47] Autoimmune Effect of Antibodies against the SARS-CoV-2 Nucleoprotein
    Matyushkina, Daria
    Shokina, Varvara
    Tikhonova, Polina
    Manuvera, Valentin
    Shirokov, Dmitry
    Kharlampieva, Daria
    Lazarev, Vasily
    Varizhuk, Anna
    Vedekhina, Tatiana
    Pavlenko, Alexander
    Penkin, Leonid
    Arapidi, Georgij
    Pavlov, Konstantin
    Pushkar, Dmitry
    Kolontarev, Konstantin
    Rumyantsev, Alexander
    Rumyantsev, Sergey
    Rychkova, Lyubov
    Govorun, Vadim
    VIRUSES-BASEL, 2022, 14 (06):
  • [48] SARS-CoV-2 vaccine, a new autoimmune hepatitis trigger?
    Romero-Salazar, Francisco Lopez
    Lista, Marina Veras
    Gomez Dominguez, Elena
    de Andres, Carolina Ibarrola
    Gomez, Raquel Munoz
    Vazquez, Inmaculada Fernandez
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (09) : 567 - 568
  • [49] SARS-CoV-2 Vaccine Response in Patients With Autoimmune Hepatitis
    Schneider, Lisa
    Schubert, Lorenz
    Winkler, Florian
    Munda, Petra
    Winkler, Stefan
    Tobudic, Selma
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (09) : 2145 - +
  • [50] SARS-Cov-2 vaccination is safe in autoimmune pancreatitis patients
    Perkhofer, Lukas
    Kilani, Katja
    Wieser, Aegaedius
    Seufferlein, Thomas
    Kleger, Pauline
    Mueller, Martin
    Kleger, Alexander
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024, 12 (01) : 159 - 161